METHOD FOR ENDOSCOPIC TREATMENT OF PATIENTS WITH NEPHROLITHIASIS USING ALPHA-BLOCKERS Russian patent published in 2022 - IPC A61B17/00 A61K31/18 A61K31/4045 A61P13/04 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to urology, and can be used in the endoscopic treatment of patients with nephrolithiasis. The installation of the ureteral casing is performed, followed by the passage of a flexible ureterorenoscope through it into the cavitary system of the kidney. Then, lithotripsy is performed using an intracorporeal contact laser lithotripter, followed by lithoextraction. At the same time, 7 days before surgery, daily drug therapy is carried out, which consists in taking drugs from the group of alpha-adrenergic blockers tamsulosin or silodosin with a multiplicity of 1 time per day.

EFFECT: method reduces the risk of intraoperative trauma to the ureter, reduces the radiographic load on the patient's body, and also excludes stent-associated symptoms due to the use of alpha-adrenergic blockers before lithotripsy.

1 cl, 2 ex